ArticleFrontiers in oncology2026
Integrated ultrasound-based radiomics and deep learning models in screening breast intraductal high-risk lesions or carcinoma: a multicenter retrospective study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of this study was to explore the diagnostic performance of ultrasound (US)-based radiomics combined with deep learning (DL) in the screening of high-risk and malignant intraductal breast lesions. Methods: This multicenter retrospective study included patients with breast intraductal lesions from January 2022 to June 2024 from five hospitals in China. In the training set, conventional US images were segmented and radiomics features were extracted. After feature selection using least absolute shrinkage and selection operator (LASSO) regression, a radiomics model was developed using logistic regression, and the DL model was constructed based on ResNet-50. An integrated model was constructed by fusing the predicted probabilities from single models. The diagnostic performance of US, radiomics, DL, and integrated models was compared in the internal and external validation sets. Results: A total of 785 lesions were collected, including 486 benign lesions and 299 high-risk or malignant lesions. In the training set (520 lesions), the integrated model achieved superior performance (area under the curve (AUC) = 0.946 [0.923, 0.964]) to that of the US model (AUC = 0.774 [0.732, 0.816]; Conclusion: The integrated radiomics and DL model demonstrated potential clinical value in screening the high-risk or malignant breast intraductal lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.